Michelle Primeau, MD
Sleep Medicine · Sunnyvale, CANPI 1588862486
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,594 of the $12,535 with a category attached, or 92.5%. Pear Therapeutics (US), Inc. accounts for 92.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $9,228 and has fallen 98.1% since, to $175 in 2025.
Across 19 payments — averaging $659.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pear Therapeutics (US), Inc.$12K
- Jazz Pharmaceuticals Inc.$595
- Inspire Medical Systems, Inc.$323
- Harmony Biosciences LLC$23
What the payments were for
- Consulting fees$11,59492%
- Food & beverage$8867%
- Education$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pear Therapeutics (US), Inc. | 3 | $11,594 |
| Jazz Pharmaceuticals Inc. | 7 | $595 |
| Inspire Medical Systems, Inc. | 8 | $323 |
| Harmony Biosciences LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,535 in reported general payments places this provider in the 85th percentile of 200 sleep medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 37 | $438 |
| Trazodone Hcl | 15 | $248 |
| Zolpidem Tartrate | 12 | $145 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Sunnyvale
- Mahesh ShettySunnyvale$4K
- Lisa ShivesSan Diego$1.4M
- Haramandeep SinghSan Ramon$1.1M
- Atul MalhotraSan Diego$771K
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Sam KashaniSanta Monica$221K
- Emmanuel MignotStanford$135K
- Jerome HesterPalo Alto$74K
- Mark BuchfuhrerDowney$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.